Urologic surgery in a safe hospital during the COVID-19 pandemic scenario.


Journal

Minerva urology and nephrology
ISSN: 2724-6442
Titre abrégé: Minerva Urol Nephrol
Pays: Italy
ID NLM: 101777299

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 24 6 2020
medline: 16 7 2021
entrez: 24 6 2020
Statut: ppublish

Résumé

The COVID-19 pandemic induced a global emergency that overwhelmed most hospitals around the world. Access to hospitals has been restricted to selective oncological and urgent patients to minimize surgeries requiring Intensive Care Unit care. All other kind of non-urgent and benign surgeries have been rescheduled. The burden of oncological and urgent cases on the healthcare system has increased. We have been asked to become the referral center for major oncological and urgent urological surgeries, increasing our surgical volume. Through meticulous hospital protocols on PPE, use of nasopharyngeal swabs, controlled hospital access and the prompt management of suspected/positive cases, we were able to perform 31% more urological surgical procedures during the COVID-19 pandemic compared to the same period in 2019. We observed a 72% increase in oncological surgical procedures and 150% in urgent procedures. Our experience shows how the management of oncological and urgent cases can be maintained during unexpected, global emergencies, such as COVID-19.

Sections du résumé

BACKGROUND
The COVID-19 pandemic induced a global emergency that overwhelmed most hospitals around the world. Access to hospitals has been restricted to selective oncological and urgent patients to minimize surgeries requiring Intensive Care Unit care. All other kind of non-urgent and benign surgeries have been rescheduled. The burden of oncological and urgent cases on the healthcare system has increased.
METHODS
We have been asked to become the referral center for major oncological and urgent urological surgeries, increasing our surgical volume. Through meticulous hospital protocols on PPE, use of nasopharyngeal swabs, controlled hospital access and the prompt management of suspected/positive cases, we were able to perform 31% more urological surgical procedures during the COVID-19 pandemic compared to the same period in 2019.
RESULTS
We observed a 72% increase in oncological surgical procedures and 150% in urgent procedures.
CONCLUSIONS
Our experience shows how the management of oncological and urgent cases can be maintained during unexpected, global emergencies, such as COVID-19.

Identifiants

pubmed: 32573174
pii: S0393-2249.20.03923-5
doi: 10.23736/S2724-6051.20.03923-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

384-391

Auteurs

Rocco Papalia (R)

Department of Urology, Campus Bio-Medico University, Rome, Italy.

Rita Cataldo (R)

Unit of Anesthesiology, Intensive Care and Pain Management, Department of Medicine, Campus Bio-Medico University, Rome, Italy.

Rossana Alloni (R)

Clinical Direction, Campus Bio-Medico University, Rome, Italy.

Karl H Pang (KH)

Unit of Academic Urology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

Antonio Alcini (A)

Department of Urology, Campus Bio-Medico University, Rome, Italy.

Gerardo Flammia (G)

Department of Urology, Campus Bio-Medico University, Rome, Italy.

Annamaria Salerno (A)

Department of Urology, Campus Bio-Medico University, Rome, Italy.

Maria G Notarangelo (MG)

Health Direction, Campus Bio-Medico University, Rome, Italy.

Silvia Angeletti (S)

Unit of Clinical Laboratory Science, Campus Bio-Medico University, Rome, Italy.

Antonella Venditti (A)

Health Direction, Campus Bio-Medico University, Rome, Italy.

Lorenzo Sommella (L)

Health Direction, Campus Bio-Medico University, Rome, Italy.

Roberto M Scarpa (RM)

Department of Urology, Campus Bio-Medico University, Rome, Italy.

Francesco Esperto (F)

Department of Urology, Campus Bio-Medico University, Rome, Italy - francescoesperto@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH